Skip to main content

Table 5 The prevalence of HCV antibody-positive patients sorted by their treatment method, at the end of 2018

From: 2018 annual dialysis data report of the JSDT Renal Data Registry: patients with hepatitis

Treatment method

HCV antibody-negative

HCV antibody-positive

Subtotal

Unspecified

No data available

Total

HCV antibody positivity rate (%)

Hemodialysis

152,905

7413

160,318

5205

28,956

194,479

4.62

Hemodiafiltration

95,677

4946

100,623

4147

16,864

121,634

4.92

Hemofiltration

8

0

8

2

2

12

0.00

Blood adsorption dialysis

995

219

1214

40

180

1434

18.04

Home hemodialysis

533

10

543

20

145

708

1.84

Peritoneal dialysis

5815

146

5961

384

2724

9069

2.45

Subtotal

255,933

12,734

268,667

9798

48,871

327,336

4.74

Unspecified/no data available

0

0

0

0

0

0

 

Total

255,933

12,734

268,667

9798

48,871

327,336

4.74

  1. The data were obtained from the patient survey
  2. HCV hepatitis C virus